skip to main content
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults
Material Type:
Artigo
Adicionar ao Meu Espaço

Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults

Jackson, Sam ; Lentino, Joseph ; Kopp, James ; Murray, Linda ; Ellison, William ; Rhee, Margaret ; Shockey, Gerald ; Akella, Lalith ; Erby, Kimberly ; Heyward, William L. ; Janssen, Robert S. ; Adams, Michael ; Bolshoun, David ; Bruce, Tami ; Chuang, Rita ; DeSantis, Donna ; Fiel, Thomas ; Fitzgibbons, William ; Francyk, David ; Geisberg, Harry ; Giep, Son ; Godbole, Narendra ; Haas, Terry ; Halpern, Stephen ; Inzerello, Anthony ; Jennings, William ; Kaiser, Scott ; Kay, Jennifer ; Kirby, William ; Lending, Robert ; Levins, Peter ; Molin, Clifford ; Noss, Michael ; Kotek, Larry ; Reynolds, Michele ; Riffer, Ernie ; Schumacher, Douglas ; Severance, Randall ; Solano, Royce ; Tejada, Albert ; Tharenos, Leslie ; Throne, Martin ; Turner, Merle ; Wolf, Thomas ; Woodruff, Mark

Vaccine, 2018-01, Vol.36 (5), p.668-674 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

2
Mivavotinib, a Syk Inhibitor, in Relapsed/Refractory (R/R) Non-GCB Diffuse Large B-Cell Lymphoma (DLBCL) with or without MYD88 and/or CD79 Mutations: A Phase 2 Study
Material Type:
Artigo
Adicionar ao Meu Espaço

Mivavotinib, a Syk Inhibitor, in Relapsed/Refractory (R/R) Non-GCB Diffuse Large B-Cell Lymphoma (DLBCL) with or without MYD88 and/or CD79 Mutations: A Phase 2 Study

Karmali, Reem ; Landsburg, Daniel J. ; Westin, Jason ; Leonard, John P. ; Kuriakose, Emil T. ; Sumrow, Bradley James ; Carroll, Susheela ; Albert, Katherine ; Akella, Lalith ; Gordon, Leo I.

Blood, 2022-11, Vol.140 (Supplement 1), p.12125-12126 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

3
Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial

Lee, Chung-Han ; Motzer, Robert ; Emamekhoo, Hamid ; Matrana, Marc ; Percent, Ivor ; Hsieh, James J ; Hussain, Arif ; Vaishampayan, Ulka ; Liu, Sandy ; McCune, Steven ; Patel, Vijay ; Shaheen, Montaser ; Bendell, Johanna ; Fan, Alice C ; Gartrell, Benjamin A ; Goodman, Oscar B ; Nikolinakos, Petros G ; Kalebasty, Arash Rezazadeh ; Zakharia, Yousef ; Zhang, Zhentao ; Parmar, Hema ; Akella, Lalith ; Orford, Keith ; Tannir, Nizar M

Clinical cancer research, 2022-08, Vol.28 (15), p.3248-3255 [Periódico revisado por pares]

United States

Texto completo disponível

4
Telaglenastat Plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 ENTRATA Trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Telaglenastat Plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 ENTRATA Trial

Lee, Chung-Han ; Motzer, Robert ; Emamekhoo, Hamid ; Matrana, Marc ; Percent, Ivor ; Hsieh, James J. ; Hussain, Arif ; Vaishampayan, Ulka ; Liu, Sandy ; McCune, Steven ; Patel, Vijay ; Shaheen, Montaser ; Bendell, Johanna ; Fan, Alice C. ; Gartrell, Benjamin A. ; Goodman, Oscar B. ; Nikolinakos, Petros G. ; Kalebasty, Arash Rezazadeh ; Zakharia, Yousef ; Zhang, Zhentao ; Parmar, Hema ; Akella, Lalith ; Orford, Keith ; Tannir, Nizar M.

Clinical cancer research, 2022-08, Vol.28 (15), p.3248-3255 [Periódico revisado por pares]

Texto completo disponível

5
Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial

Tannir, Nizar M ; Agarwal, Neeraj ; Porta, Camillo ; Lawrence, Nicola J ; Motzer, Robert ; McGregor, Bradley ; Lee, Richard J ; Jain, Rohit K ; Davis, Nancy ; Appleman, Leonard J ; Goodman, Oscar ; Stadler, Walter M ; Gandhi, Sunil ; Geynisman, Daniel M ; Iacovelli, Roberto ; Mellado, Begoña ; Sepúlveda Sánchez, Juan Manuel ; Figlin, Robert ; Powles, Thomas ; Akella, Lalith ; Orford, Keith ; Escudier, Bernard

JAMA oncology, 2022-10, Vol.8 (10), p.1411-1418 [Periódico revisado por pares]

American Medical Association

Texto completo disponível

6
CANTATA: Primary analysis of a global, randomized, placebo (Pbo)-controlled, double-blind trial of telaglenastat (CB-839) + cabozantinib versus Pbo + cabozantinib in advanced/metastatic renal cell carcinoma (mRCC) patients (pts) who progressed on immune checkpoint inhibitor (ICI) or anti-angiogenic therapies
Material Type:
Artigo
Adicionar ao Meu Espaço

CANTATA: Primary analysis of a global, randomized, placebo (Pbo)-controlled, double-blind trial of telaglenastat (CB-839) + cabozantinib versus Pbo + cabozantinib in advanced/metastatic renal cell carcinoma (mRCC) patients (pts) who progressed on immune checkpoint inhibitor (ICI) or anti-angiogenic therapies

Tannir, Nizar M. ; Agarwal, Neeraj ; Porta, Camillo ; Lawrence, Nicola Jane ; Motzer, Robert J. ; Lee, Richard J. ; Jain, Rohit K. ; Davis, Nancy B. ; Appleman, Leonard Joseph ; Goodman, Oscar B. ; Stadler, Walter Michael ; Gandhi, Sunil G. ; Geynisman, Daniel M. ; Iacovelli, Roberto ; Mellado, Begona ; Figlin, Robert A. ; Powles, Thomas ; Akella, Lalith V ; Orford, Keith W. ; Escudier, Bernard

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.4501-4501 [Periódico revisado por pares]

Texto completo disponível

7
Immunogenicity of Investigational 2-Dose Hepatitis B Vaccine, HEPLISAV-B, Compared With a Licensed Vaccine (ENGERIX-B) in Adults With Factors That Reduce Immune Responses
Material Type:
Artigo
Adicionar ao Meu Espaço

Immunogenicity of Investigational 2-Dose Hepatitis B Vaccine, HEPLISAV-B, Compared With a Licensed Vaccine (ENGERIX-B) in Adults With Factors That Reduce Immune Responses

Jackson, Sam ; Erby, Kim ; Akella, Lalith ; Heyward, William L. ; Hyer, Randy ; Janssen, Robert

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1) [Periódico revisado por pares]

Texto completo disponível

8
PL2: Towards Predictable Low Latency in Rack-Scale Networks
Material Type:
Artigo
Adicionar ao Meu Espaço

PL2: Towards Predictable Low Latency in Rack-Scale Networks

Le, Yanfang ; Radhika Niranjan Mysore ; Suresh, Lalith ; Zellweger, Gerd ; Banerjee, Sujata ; Akella, Aditya ; Swift, Michael

arXiv.org, 2021-01

Ithaca: Cornell University Library, arXiv.org

Texto completo disponível

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (7)

Data de Publicação 

De até

Buscando em bases de dados remotas. Favor aguardar.